side effects of taking too much semaglutide GLP-1 drugs such as and tirzepatide are transforming obesity and diabetes care in India, but experts warn that improper use could lead to significant muscle loss. A new India-specific consensus highlights What happens if you take

human data is limited and mixed Safety flags Possible reactions, high-dose IV concerns, unregulated product quality Cost Varies This page Education only, not medical advice or a recommendation This page is educational and not medical advice

Thinking you can apply one drug's schedule to another is a recipe for disappointment, or worse, significant discomfort

While not listed among common side effects in clinical trials, cold sensitivity is increasingly reported by patients taking this medication

Chopra of their patients seeking the fat vampire

Market Size (2026): USD 2.4 Bn Forecast (2036): USD 10.9 Bn CAGR (2026 to 2036): 16.3% GLP-1 Meal Replacement Market Size, Market Forecast and Outlook By FMI The GLP-1 meal replacement market is projected to grow from USD 2.4 billion in 2026 to USD 10.9 billion by 2036, at a CAGR of 16.3%